NURS 5334 – COMPREHENSIVE QUESTIONS
AND ANSWERS | VERIFIED AND WELLDETAILED ANSWERS | DETAILED EXPLANATIONS AND
RATIONALES | COMPLETE EXAM PREPARATION STUDY GUIDE | PRACTICE QUESTIONS |
LATEST EXAM UPDATE
• CORE DOMAINS *
•
1. Pharmacological Principles, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism
2. Autonomic Nervous System Pharmacology
3. Cardiovascular, Hematologic, and Lipid-Lowering Pharmacotherapy
4. Psychopharmacology and Central Nervous System Pharmacology
5. Endocrine, Diabetes, Thyroid, and Metabolic Pharmacotherapy
6. Pain, Musculoskeletal, Bone, and Joint Pharmacotherapy
7. Anti-Infective, Antifungal, Antiviral, Respiratory, and Tuberculosis Pharmacotherapy
8. Reproductive, Genitourinary, Sexually Transmitted Infection, and HIV Pharmacotherapy
9. Gastrointestinal, Vitamin, and Anti-Obesity Pharmacotherapy
10. Prescribing, Patient Education, Safety, Monitoring, Interactions, and Lifespan
Considerations
• INTRODUCTION *
•
This comprehensive assessment is designed to evaluate advanced pharmacology knowledge
and clinical decision-making expected in NURS 5334. The questions integrate
pharmacokinetics, pharmacodynamics, mechanisms of action, therapeutic indications,
contraindications, adverse effects, interactions, monitoring, prescribing considerations,
patient education, and application across the lifespan. Multiple-choice questions progress
from foundational concepts to clinical scenarios requiring interpretation and judgment. The
assessment emphasizes understanding why a medication is appropriate, how patient
characteristics influence therapy, how treatment should be monitored, and how potential
risks can be recognized and managed. The material is intended to strengthen examination
preparation while promoting safe, evidence-informed pharmacologic reasoning in advanced
nursing practice.
SECTION ONE: QUESTIONS 1–100
PHARMACOLOGICAL PRINCIPLES, PHARMACOKINETICS, AND PHARMACODYNAMICS
,Question 1. A medication is highly lipid soluble and readily crosses cell membranes. Which
pharmacokinetic property is most directly associated with this characteristic?
A. Poor tissue penetration
B. Extensive distribution into tissues
C. Complete renal elimination
D. Minimal volume of distribution
Correct Answer: B. Extensive distribution into tissues
Explanation: Lipid-soluble medications readily cross biological membranes and may
distribute extensively into tissues. This can increase the volume of distribution and
sometimes prolong the drug's elimination because tissue stores can act as reservoirs.
Question 2. A patient with severe hypoalbuminemia is prescribed a medication that is
normally highly protein bound. What pharmacologic consequence should the nurse
anticipate?
A. Decreased free drug concentration
B. Increased free drug concentration
C. Complete prevention of hepatic metabolism
D. Increased renal tubular secretion of the bound drug
Correct Answer: B. Increased free drug concentration
Explanation: Albumin binds many acidic and neutral medications in the bloodstream. When
albumin levels are reduced, less drug is protein bound and more remains pharmacologically
active in the free form, potentially increasing toxicity.
Question 3. Which pharmacokinetic process describes movement of a drug from the
gastrointestinal tract into systemic circulation?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A. Absorption
Explanation: Absorption is the movement of a drug from its administration site into systemic
circulation. Oral drugs must generally dissolve and cross gastrointestinal membranes before
reaching the bloodstream.
,Question 4. A patient receives a medication by intravenous bolus. Which pharmacokinetic
process is essentially bypassed?
A. Distribution
B. Metabolism
C. Absorption
D. Elimination
Correct Answer: C. Absorption
Explanation: Intravenous administration places the drug directly into systemic circulation, so
the traditional absorption phase is bypassed. Distribution, metabolism, and elimination still
occur.
Question 5. A medication has a half-life of 8 hours. Approximately how long would it take for
most of the drug to be eliminated after discontinuation, assuming first-order kinetics?
A. 8 hours
B. 16 hours
C. 24 hours
D. 40 hours
Correct Answer: D. 40 hours
Explanation: Approximately five half-lives are required to eliminate about 97% of a drug.
Five half-lives of 8 hours equal approximately 40 hours.
Question 6. Which statement best describes pharmacodynamics?
A. How the body absorbs and eliminates a medication
B. How a medication is distributed through body compartments
C. How a medication produces effects in the body
D. How a medication is excreted through the kidneys
Correct Answer: C. How a medication produces effects in the body
Explanation: Pharmacodynamics concerns the relationship between drug concentration and
drug effects, including receptor interactions, mechanisms of action, therapeutic effects, and
adverse effects.
Question 7. A drug binds to a receptor and produces the maximum biologic response that
the receptor system can generate. How is this drug best classified?
, A. Competitive antagonist
B. Partial agonist
C. Full agonist
D. Inverse transporter
Correct Answer: C. Full agonist
Explanation: A full agonist binds to a receptor and activates it sufficiently to produce the
maximal response available from that receptor system.
Question 8. A medication binds to a receptor but produces less than the maximal possible
response even when all receptors are occupied. What is this medication?
A. Full agonist
B. Partial agonist
C. Irreversible antagonist
D. Enzyme inducer
Correct Answer: B. Partial agonist
Explanation: A partial agonist activates a receptor but produces a lower maximal response
than a full agonist. In the presence of a full agonist, it can sometimes functionally reduce the
overall response by competing for receptor occupancy.
Question 9. A patient takes two medications that are both metabolized by the same hepatic
enzyme. What is the primary concern?
A. The drugs will necessarily have identical therapeutic effects
B. One medication may alter the concentration of the other
C. Both medications will automatically be eliminated faster
D. The drugs cannot be administered together under any circumstances
Correct Answer: B. One medication may alter the concentration of the other
Explanation: Drugs sharing metabolic pathways can compete for enzymes or alter enzyme
activity. One medication may inhibit or induce metabolism of another, changing its plasma
concentration and clinical effect.
Question 10. Which patient is most likely to experience prolonged effects from a medication
primarily eliminated by the kidneys?
A. A young adult with normal renal function
B. An older adult with significantly reduced renal function
AND ANSWERS | VERIFIED AND WELLDETAILED ANSWERS | DETAILED EXPLANATIONS AND
RATIONALES | COMPLETE EXAM PREPARATION STUDY GUIDE | PRACTICE QUESTIONS |
LATEST EXAM UPDATE
• CORE DOMAINS *
•
1. Pharmacological Principles, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism
2. Autonomic Nervous System Pharmacology
3. Cardiovascular, Hematologic, and Lipid-Lowering Pharmacotherapy
4. Psychopharmacology and Central Nervous System Pharmacology
5. Endocrine, Diabetes, Thyroid, and Metabolic Pharmacotherapy
6. Pain, Musculoskeletal, Bone, and Joint Pharmacotherapy
7. Anti-Infective, Antifungal, Antiviral, Respiratory, and Tuberculosis Pharmacotherapy
8. Reproductive, Genitourinary, Sexually Transmitted Infection, and HIV Pharmacotherapy
9. Gastrointestinal, Vitamin, and Anti-Obesity Pharmacotherapy
10. Prescribing, Patient Education, Safety, Monitoring, Interactions, and Lifespan
Considerations
• INTRODUCTION *
•
This comprehensive assessment is designed to evaluate advanced pharmacology knowledge
and clinical decision-making expected in NURS 5334. The questions integrate
pharmacokinetics, pharmacodynamics, mechanisms of action, therapeutic indications,
contraindications, adverse effects, interactions, monitoring, prescribing considerations,
patient education, and application across the lifespan. Multiple-choice questions progress
from foundational concepts to clinical scenarios requiring interpretation and judgment. The
assessment emphasizes understanding why a medication is appropriate, how patient
characteristics influence therapy, how treatment should be monitored, and how potential
risks can be recognized and managed. The material is intended to strengthen examination
preparation while promoting safe, evidence-informed pharmacologic reasoning in advanced
nursing practice.
SECTION ONE: QUESTIONS 1–100
PHARMACOLOGICAL PRINCIPLES, PHARMACOKINETICS, AND PHARMACODYNAMICS
,Question 1. A medication is highly lipid soluble and readily crosses cell membranes. Which
pharmacokinetic property is most directly associated with this characteristic?
A. Poor tissue penetration
B. Extensive distribution into tissues
C. Complete renal elimination
D. Minimal volume of distribution
Correct Answer: B. Extensive distribution into tissues
Explanation: Lipid-soluble medications readily cross biological membranes and may
distribute extensively into tissues. This can increase the volume of distribution and
sometimes prolong the drug's elimination because tissue stores can act as reservoirs.
Question 2. A patient with severe hypoalbuminemia is prescribed a medication that is
normally highly protein bound. What pharmacologic consequence should the nurse
anticipate?
A. Decreased free drug concentration
B. Increased free drug concentration
C. Complete prevention of hepatic metabolism
D. Increased renal tubular secretion of the bound drug
Correct Answer: B. Increased free drug concentration
Explanation: Albumin binds many acidic and neutral medications in the bloodstream. When
albumin levels are reduced, less drug is protein bound and more remains pharmacologically
active in the free form, potentially increasing toxicity.
Question 3. Which pharmacokinetic process describes movement of a drug from the
gastrointestinal tract into systemic circulation?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A. Absorption
Explanation: Absorption is the movement of a drug from its administration site into systemic
circulation. Oral drugs must generally dissolve and cross gastrointestinal membranes before
reaching the bloodstream.
,Question 4. A patient receives a medication by intravenous bolus. Which pharmacokinetic
process is essentially bypassed?
A. Distribution
B. Metabolism
C. Absorption
D. Elimination
Correct Answer: C. Absorption
Explanation: Intravenous administration places the drug directly into systemic circulation, so
the traditional absorption phase is bypassed. Distribution, metabolism, and elimination still
occur.
Question 5. A medication has a half-life of 8 hours. Approximately how long would it take for
most of the drug to be eliminated after discontinuation, assuming first-order kinetics?
A. 8 hours
B. 16 hours
C. 24 hours
D. 40 hours
Correct Answer: D. 40 hours
Explanation: Approximately five half-lives are required to eliminate about 97% of a drug.
Five half-lives of 8 hours equal approximately 40 hours.
Question 6. Which statement best describes pharmacodynamics?
A. How the body absorbs and eliminates a medication
B. How a medication is distributed through body compartments
C. How a medication produces effects in the body
D. How a medication is excreted through the kidneys
Correct Answer: C. How a medication produces effects in the body
Explanation: Pharmacodynamics concerns the relationship between drug concentration and
drug effects, including receptor interactions, mechanisms of action, therapeutic effects, and
adverse effects.
Question 7. A drug binds to a receptor and produces the maximum biologic response that
the receptor system can generate. How is this drug best classified?
, A. Competitive antagonist
B. Partial agonist
C. Full agonist
D. Inverse transporter
Correct Answer: C. Full agonist
Explanation: A full agonist binds to a receptor and activates it sufficiently to produce the
maximal response available from that receptor system.
Question 8. A medication binds to a receptor but produces less than the maximal possible
response even when all receptors are occupied. What is this medication?
A. Full agonist
B. Partial agonist
C. Irreversible antagonist
D. Enzyme inducer
Correct Answer: B. Partial agonist
Explanation: A partial agonist activates a receptor but produces a lower maximal response
than a full agonist. In the presence of a full agonist, it can sometimes functionally reduce the
overall response by competing for receptor occupancy.
Question 9. A patient takes two medications that are both metabolized by the same hepatic
enzyme. What is the primary concern?
A. The drugs will necessarily have identical therapeutic effects
B. One medication may alter the concentration of the other
C. Both medications will automatically be eliminated faster
D. The drugs cannot be administered together under any circumstances
Correct Answer: B. One medication may alter the concentration of the other
Explanation: Drugs sharing metabolic pathways can compete for enzymes or alter enzyme
activity. One medication may inhibit or induce metabolism of another, changing its plasma
concentration and clinical effect.
Question 10. Which patient is most likely to experience prolonged effects from a medication
primarily eliminated by the kidneys?
A. A young adult with normal renal function
B. An older adult with significantly reduced renal function
